About GenXys
GenXys is a company based in Vancouver (Canada) founded in 2014 by Martin Dawes. GenXys has raised $1.33 million across 2 funding rounds from investors including GreenShield, TYDO INCUBATOR and TELUS Ventures. GenXys offers products and services including LabGx, CDSS, and OptimizeGx. GenXys operates in a competitive market with competitors including Invitae, Newtopia, VitaminLab, Inagene and GeneYouIn, among others.
- Headquarter Vancouver, Canada
- Founders Martin Dawes
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.33 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
GreenShield
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenXys
GenXys offers a comprehensive portfolio of products and services, including LabGx, CDSS, and OptimizeGx.
Integrates genomic data for clinical decision-making in prescribing.
Delivers personalized treatment recommendations based on patient profiles.
Streamlines authorization processes for specialty medications.
People of GenXys
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of GenXys
GenXys has successfully raised a total of $1.33M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(03 Apr 2019)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Seed - GenXys | Valuation | GSC |
|
| Apr, 2019 | Amount | Seed - GenXys | Valuation | TYDO INCUBATOR , TELUS Ventures |
|
Investors in GenXys
GenXys has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include GreenShield, TYDO INCUBATOR and TELUS Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investments in multiple sectors are directed by TELUS Ventures.
|
Founded Year | Domain | Location | |
|
GreenShield is recognized for providing integrated health coverage and care.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenXys
Financial Statements - GenXys
Genxys Comparisons
Competitors of GenXys
GenXys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Invitae, Newtopia, VitaminLab, Inagene and GeneYouIn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Health management platform is provided for employers and insurers.
|
|
| domain | founded_year | HQ Location |
Personalized supplements are developed using blood and genetic tests.
|
|
| domain | founded_year | HQ Location |
Provider of genetic test for pain management
|
|
| domain | founded_year | HQ Location |
Provider of solutions to patients and their healthcare practitioners by providing insight into how they respond to specific medications based on their genetic profile
|
Frequently Asked Questions about GenXys
GenXys was founded in 2014 and raised its 1st funding round 5 years after it was founded.
GenXys is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Martin Dawes is the current CEO of GenXys. They have also founded this company.
GenXys is a funded company, having raised a total of $1.33M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.33M, raised on Apr 03, 2019.
GenXys was founded in 2014 in Vancouver, Canada, within the healthcare sector focused on pharmacogenetics. Services include TreatGxPlus, a home collection kit ordered by consumers for genetic variant analysis affecting medication responses, with reports shared for professional consultations. TreatGx, a decision support tool, is offered to healthcare providers, integrating pharmacogenetic data, medical history, and clinical evidence to suggest tailored medication options. Operations emphasize evidence-based personalization across North America.
GenXys's top competitors include Newtopia, Invitae and VitaminLab.
GenXys offers LabGx, CDSS, and OptimizeGx.
GenXys has 3 investors. Key investors include GreenShield, TYDO INCUBATOR, and TELUS Ventures.